Cost Considerations with Tight Glycemic Control in the Acute Care Setting

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Hyperglycemia is associated with increased morbidity and mortality in critically ill patients. Clinical trial data has demonstrated that controlling hyperglycemia with insulin infusions guided by frequent blood glucose monitoring can reduce this morbidity and mortality. Pharmacoeconomic analyses of these studies have found that tight glycemic control in the critically ill patient is highly cost-effective. Given the relatively small cost of achieving tight glycemic control (about $200 per patient), most economic analyses have demonstrated that tight glycemic control protocols are actually cost saving. Based on the outcomes of cardiac surgery and intensive care unit studies, the cost per life year gained resulting from the implementation of tight glycemic control protocols is less than $6000 (highly cost-effective). Benefits of implementing tight glycemic control protocols in critical or intensive care units includes not only reductions in morbidity and mortality, but reductions in hospital costs.

Original languageEnglish
Pages (from-to)359-365
Number of pages7
JournalSeminars in Thoracic and Cardiovascular Surgery
Volume18
Issue number4
DOIs
StatePublished - 2006

Fingerprint

Costs and Cost Analysis
Morbidity
Critical Illness
Hyperglycemia
Intensive Care Units
Mortality
Pharmaceutical Economics
Hospital Costs
Critical Care
Thoracic Surgery
Blood Glucose
Economics
Clinical Trials
Insulin

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Cost Considerations with Tight Glycemic Control in the Acute Care Setting. / Hilleman, Daniel E.

In: Seminars in Thoracic and Cardiovascular Surgery, Vol. 18, No. 4, 2006, p. 359-365.

Research output: Contribution to journalArticle

@article{9ae49095c7184e77871a128f167f6e45,
title = "Cost Considerations with Tight Glycemic Control in the Acute Care Setting",
abstract = "Hyperglycemia is associated with increased morbidity and mortality in critically ill patients. Clinical trial data has demonstrated that controlling hyperglycemia with insulin infusions guided by frequent blood glucose monitoring can reduce this morbidity and mortality. Pharmacoeconomic analyses of these studies have found that tight glycemic control in the critically ill patient is highly cost-effective. Given the relatively small cost of achieving tight glycemic control (about $200 per patient), most economic analyses have demonstrated that tight glycemic control protocols are actually cost saving. Based on the outcomes of cardiac surgery and intensive care unit studies, the cost per life year gained resulting from the implementation of tight glycemic control protocols is less than $6000 (highly cost-effective). Benefits of implementing tight glycemic control protocols in critical or intensive care units includes not only reductions in morbidity and mortality, but reductions in hospital costs.",
author = "Hilleman, {Daniel E.}",
year = "2006",
doi = "10.1053/j.semtcvs.2006.12.004",
language = "English",
volume = "18",
pages = "359--365",
journal = "Seminars in Thoracic and Cardiovascular Surgery",
issn = "1043-0679",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Cost Considerations with Tight Glycemic Control in the Acute Care Setting

AU - Hilleman, Daniel E.

PY - 2006

Y1 - 2006

N2 - Hyperglycemia is associated with increased morbidity and mortality in critically ill patients. Clinical trial data has demonstrated that controlling hyperglycemia with insulin infusions guided by frequent blood glucose monitoring can reduce this morbidity and mortality. Pharmacoeconomic analyses of these studies have found that tight glycemic control in the critically ill patient is highly cost-effective. Given the relatively small cost of achieving tight glycemic control (about $200 per patient), most economic analyses have demonstrated that tight glycemic control protocols are actually cost saving. Based on the outcomes of cardiac surgery and intensive care unit studies, the cost per life year gained resulting from the implementation of tight glycemic control protocols is less than $6000 (highly cost-effective). Benefits of implementing tight glycemic control protocols in critical or intensive care units includes not only reductions in morbidity and mortality, but reductions in hospital costs.

AB - Hyperglycemia is associated with increased morbidity and mortality in critically ill patients. Clinical trial data has demonstrated that controlling hyperglycemia with insulin infusions guided by frequent blood glucose monitoring can reduce this morbidity and mortality. Pharmacoeconomic analyses of these studies have found that tight glycemic control in the critically ill patient is highly cost-effective. Given the relatively small cost of achieving tight glycemic control (about $200 per patient), most economic analyses have demonstrated that tight glycemic control protocols are actually cost saving. Based on the outcomes of cardiac surgery and intensive care unit studies, the cost per life year gained resulting from the implementation of tight glycemic control protocols is less than $6000 (highly cost-effective). Benefits of implementing tight glycemic control protocols in critical or intensive care units includes not only reductions in morbidity and mortality, but reductions in hospital costs.

UR - http://www.scopus.com/inward/record.url?scp=33947528255&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947528255&partnerID=8YFLogxK

U2 - 10.1053/j.semtcvs.2006.12.004

DO - 10.1053/j.semtcvs.2006.12.004

M3 - Article

VL - 18

SP - 359

EP - 365

JO - Seminars in Thoracic and Cardiovascular Surgery

JF - Seminars in Thoracic and Cardiovascular Surgery

SN - 1043-0679

IS - 4

ER -